SCHEMBL20262016

SCHEMBL20262016

O=C(CCN1C(=O)C=CC1=O)NCCOCCOCCOCCOCCC(=O)N1CCN(C(=O)O)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.40
HSD17B10 Q99714 3/20 0.34
ALDH1A1 P00352 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
PTGS1 P23219 4/20 0.33
PTGS2 P35354 4/20 0.33
CA12 O43570 4/20 0.33
CA1 P00915 4/20 0.33
CA2 P00918 4/20 0.33
CA4 P22748 4/20 0.33
CA9 Q16790 4/20 0.33
CA14 Q9ULX7 4/20 0.33
KMT2A Q03164 1/20 0.33
MMP13 P45452 1/20 0.32
ADAMTS5 Q9UNA0 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19703937 0.87 NPC1 (0.40) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL29608026 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL29441383 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL29869052 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL30259429 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL24621693 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL29869032 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL10018583 0.85 MGLL (0.55) MGLLHSD17B10ALDH1A1SMN1; SMN2HPGD
SCHEMBL19698597 0.84 P2RY14 (0.35) MGLLSMN1; SMN2HPGDHTTKMT2A
SCHEMBL20254026 0.84 MGLL (0.47) MGLLALDH1A1SMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2836493-B1 FUNCTIONALIZED THIENO-INDOLE DERIVATIVES FOR THE TREATMENT OF CANCER NERVIANO MEDICAL SCIENCES SRL (IT) 2018-06-20 EP claimed